from RAR report

 

Aagiu A. and Botescu A.,
Update on country situation: ROMANIA. 2nd Meeting on detecting and responding to outbreaks of HIV among IDUs, Lisbon, 12th October 2012.

 

Abdala N, Grund J-PC, Tolstov Y, Kozlov AP, Heimer R.
Can homemade injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union? Addiction [Internet]. 2006 May [cited 2012 May 2];101(5):731–7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16669907

 

Alves, V. D. B. (2013).
„A ilegalidade e o desconhecimento: perceções de risco acerca das novas substâncias psicoativas.” Dissertação de Mestrado apresentada à Universidade do Porto – Faculdade de Psicologia e de Ciências da Educação. Retrieved from
http://repositorio-aberto.up.pt/bitstream/10216/71723/2/81828.pdf

 

Balsa, C.; Vital, C.; & Urbano, C. (2014).
“III Inquérito Nacional ao consumo de substâncias psicoativas na População Geral - Portugal 2012.” CESNOVA – Centro de Estudos de Sociologia da Universidade Nova de Lisboa. Lisboa: SICAD. Retrieved from
http://www.sicad.pt/BK/EstatisticaInvestigacao/EstudosConcluidos/Lists/SICAD_ESTUDOS/Attachments/135/III_InqueritoNacionalConsumo_deSPnaPG%202012.pdf

 

Calado, V. (2006).
„Drogas sintéticas: Mundos culturais, música trance e ciberespaço.” Lisboa: IDT.

 

Calado, V. (2013).
„Novas substâncias psicoactivas: O caso da Salvia Divinorum.” Lisboa: SICAD, Coleção Estudos.

 

Carvalho, A.; & Pires, I. A. (2012).
„Novas substâncias psicoativas: Risco grave para a saúde pública.” III Congresso nacional de saúde pública. Coimbra, October 25, 2012.

 

Cunha, R. (2013, November 12).
„Álcool com “presença crescente” associado a novas substâncias psicoactivas: Congresso na Universidade de Aveiro medita sobre adições. Diário de Aveiro.“ Retrieved from
http://www.diarioaveiro.pt/noticias/alcool-com-presenca-crescente-associado-novas-substancias-psicoativas

 

Dependências (2012, October).
Novas substâncias: Nelson Carvalho Diretor do Serviço de Prevenção da Toxicodependência. Dependências, p. 17-18

 

M. Mardarescu Tallinn, Estonia 29-30 March 2012.
Detecting and responding to outbreaks of HIV among people who inject drugs: Best practices in HIV prevention and control – Romania – country situation - part 1,

 

A. Abagiu and A. Botescu Tallinn, Estonia, 29-30th March 2012.
Detecting and responding to outbreaks of HIV among people who inject drugs: Best practices in HIV prevention and control; Romania – country situation - part 2,

 

Dumchev K V, Soldyshev R, Qian H-Z, Zezyulin OO, Chandler SD, Slobodyanyuk P, et al.
HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey. Harm Reduct J [Internet]. 2009 Jan [cited 2015 Oct 11];6(1):23. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2741433&tool=pmcentrez&rendertype=abstract

 

EMCDDA (2011).
Online sales of new psychoactive substances / 'legal highs': summary of results from the 2011 multilingual snapshots. Brief Paper. Available:
http://www.emcdda.europa.eu/publications/scientific-studies/2011/snapshot

 

EMCDDA (2015).
New psychoactive substances in Europe: An update from the EU Early Warning System. March 2015. Available:
http://www.emcdda.europa.eu/news/2015/1/cnd-new-drugs

 

EMCDDA/EUROPOL. (2007a).
“Europol–EMCDDA Active Monitoring Report on a new psychoactive substance: 1-(3-chlorophenyl)piperazine (mCPP).” Retrieved from
http://www.emcdda.europa.eu/themes/new-drugs/early-warning

 

EMCDDA/EUROPOL. (2007b).
“Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP).” Retrieved from
http://www.emcdda.europa.eu/html.cfm/index132204EN.html

 

EMCDDA/EUROPOL. (2010).
“Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone).” Retrieved from
http://www.emcdda.europa.eu/html.cfm/index132196EN.html

 

EMCDDA/EUROPOL. (2013).
“EMCDDA–Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole.” Retrieved from
http://www.emcdda.europa.eu/publications/joint-reports/5-IT

 

EMCDDA/EUROPOL. (2014a).
“EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone).” Retrieved from
http://www.emcdda.europa.eu/publications/joint-report/MDPV

 

EMCDDA/EUROPOL. (2014b).
“EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone).” Retrieved from
http://www.emcdda.europa.eu/publications/joint-report/methoxetamine

 

EMCDDA/EUROPOL. (2014c).
“EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine).” Retrieved from
http://www.emcdda.europa.eu/publications/joint-report/25I-NBOMe

 

EU/EEA,
following a reported increase of cases in Greece and Romania, p 3-4, EMCDDA, ECDC, 2012

 

Feijão, F. (2012a).
„Inquérito Nacional em meio escolar, 2011, 3.º ciclo: Consumo de drogas e outras substâncias psicoativas.” Lisboa: SICAD. Retrieved from
http://www.sicad.pt/PT/EstatisticaInvestigacao/EstudosConcluidos/Paginas/detalhe.aspx?itemId=129&lista=SICAD_ESTUDOS&bkUrl=/BK/EstatisticaInvestigacao/EstudosConcluidos

 

Feijão, F. (2012b).
„Inquérito Nacional em meio escolar, 2011, secundário: Consumo de drogas e outras substâncias psicoativas.” Lisboa: SICAD. Retrieved from
http://www.sicad.pt/PT/EstatisticaInvestigacao/EstudosConcluidos/Paginas/detalhe.aspx?itemId=127&lista=SICAD_ESTUDOS&bkUrl=/BK/EstatisticaInvestigacao/EstudosConcluidos

 

Ferreira, V. S., Borrego, R.; Silva, P.A., Rowland, J., Truninger, M., Lavado, E., & Melo, R. (2014).
„Consumos e estilos de vida no ensino superior: o caso dos estudantes da Universidade de Lisboa.” Lisboa: SIDAC/CNJ/OPJ.

 

Goulão, J. (2013, April/May).
Novas substâncias psicoativas. Boletim da Ordem dos Advogados, 101/102: 36-37.

 

Grund J, Coffin P, Jauffret-roustide M, Dijkstra M, Bruin D De, Bruin D de.
The fast and furious — cocaine , amphetamines and harm reduction. Harm Reduct evidence, impacts challenges [Internet]. Publications Office of the European Union; 2010 [cited 2014 Dec 27];191–232. Available from:
http://www.mendeley.com/research/fast-furious-cocaine-amphetamines-harm-reduction/?utm_source=desktop&utm_medium=1.12.4&utm_campaign=open_catalog&userDocumentId={c5051c4e-fddd-4047-9aac-d97d45aa8041}

 

Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, et al.
Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci … [Internet]. 1996 [cited 2012 Sep 13];42(5):691–703. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8685737

 

Grund JP, Kaplan CD, Adriaans NF, Blanken P.
Drug sharing and HIV transmission risks: the practice of frontloading in the Dutch injecting drug user population. J Psychoactive Drugs. 1991;23(1):1–10.

 

Grund J-P. A Candle Lit from Both Sides. Karen McElrath (ed),
HIV and AIDS: A Global View, Westport, Ct, USA, Greenwood Press, 2001 [Internet]. 2002. Available from:
http://hdl.handle.net/1765/51687

 

Grund J-PC, Zábranský T, Irwin K, Heimer R.
Stimulant use in central and eastern Europe: how recent social history shaped current drug consumption patterns. In: Pates R, Riley D, editors. Pates, R (Richard) and Diane Riley (eds), Interventions for Amphetamine Misuse [Internet]. Wiley-Blackwell; 2009 [cited 2014 Feb 17]. p. 173–202.

 

Grund, J.P. – Vavrincikova, L. et all (2014)
“Rapid Assessment & Response Guideline.” CUNI.

 

Habrat B. (2013)
„Poważne encefalopatie spowodowane związkami manganu używanymi do produkcji metkatynonu (efedronu) z leków zawierających pseudoefedrynę” (”Severe encephalopathy caused by manganese compounds used to produce methcathinone (ephedrone) of pseudoephedrine-containing medicines”) in „Serwis Informacyjny Narkomania.” Warszawa: Krajowe Biuro ds. Przeciwdziałania Narkomanii.

 

Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER.
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health [Internet]. 2001 Jan [cited 2015 Sep 8];91(1):42–6. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1446500&tool=pmcentrez&rendertype=abstract

 

Hearne E. , Alves EA, Van Hout M-C, Grund J-PC. (2015).
Home Manufacture of Drugs: A Netnographic Investigation and Toxicological Reality Check of Online Discussions on Drug Chemistry. (under review)

 

Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, et al.
Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? EUROSURVEILLANCE [Internet]. EUR CENTRE DIS PREVENTION & CONTROL, TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN; 2013 Nov [cited 2015 Mar 17];18(48):7–12. Available from: http://apps.webofknowledge.com.proxy.library.uu.nl/full_record.do?product=WOS&search_mode=GeneralSearch&qid=1&SID=P152BEcZ9jxdejPwF7j&page=1&doc=2

 

National Antidrug Agency, Romanian Angel Appeal and Carusel Association, 2012
HIV, HBV and HCV Behavioural Surveillance Survey among Injecting Drug Users in Bucharest, Romania,

 

Jabłoński P., Malczewski A. (2014).
“New psychoactive substances. Problem and response.” Warsaw: National Bureau for Drug Prevention.

 

Joint EMCDDA and ECDC rapid risk assessment 2012.
HIV in injecting drug users in the Jornal de Notícias (JN). (2012, December 28). Hospitais com mais de 30 casos por consumo de drogas legais em dois meses. Jornal de Notícias.

 

Jose B, Friedman SR, Neaigus A, Curtis R, Grund JP, Goldstein MF, et al.
Syringe-mediated drug sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS (London, … [Internet]. 1993 [cited 2012 Oct 3];7(12):1653–60. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/8286076

 

Kidawa M., Chojecki D. (2012).
New Drugs and the “Boosters” in a European and Worldwide Context. Warsaw: National Bureau for Drug Prevention. Retrieved from
http://www.narkomania.org.pl/czytelnia/nowe-narkotyki-dopalacze-kontekscie-europejskim-swiatowym

 

Koester S, Glanz J, Barón A.
Drug Sharing Among Heroin Networks: Implications for HIV and Hepatitis B and C Prevention. AIDS Behav [Internet]. 2005 Mar [cited 2015 Oct 11];9(1):27–39. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15812611

 

Koester S, Heimer R, Barón AE, Glanz J, Teng W. Re:
“Risk of hepatitis C virus among young adult injection drug users who share injection equipment”. Am J Epidemiol [Internet]. 2003 Feb 15 [cited 2015 Oct 11];157(4):376; author reply 376–8. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12578809

 

Maresia. (2012, October 29).
Smart shops - Drogas Legais - Mortes, desresponsabilização, banalização? Perigo? [Forum message]. Hen’s Health Forum.

 

Melvin, L.S., Johnson, M.R., Harbert, C.A., et al. (1984).
A cannabinoid derived prototypical analgesic. J Med Chem 27 67-71.

 

Ministério da Saúde. (2013, November 4).
Lei que proíbe a venda de substâncias psicoativas torna Portugal exemplo para a UE. Governo de Portugal. Retrieved from
http://www.portugal.gov.pt/pt/os-ministerios/ministerio-da-saude/mant

 

Moore D.
Beyond Zinberg’s “social setting”: a processural view of illicit drug use. Drug Alcohol Rev [Internet]. 1993 Jan [cited 2014 Dec 30];12(4):413–21. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/16840107

 

Moore D.
Social controls, harm minimisation and interactive outreach: the public health implications of an ethnography of drug use. Aust J Public Health. 1993;17(1):58–67.

 

Moro L. & Racz J. (2013)
Online drug user-led harm reduction in Hungary: a review of "Daath.” Harm Reduct J 10.

 

Mravčík, V. et al. (2014).
National Report: The Czech Republic – 2013 Drug Situation. MRAV otypical analgesic. J Med vlády 13 Dé republiky, s.

 

National Anti-AIDS Strategy 2011-2015,
www.ana.gov.ro

 

National RAR reports
produced by participating countries (Czech Republic, Poland, Greece, Romania, Portugal).

 

Nogueira, P. J. (2012).
Notificação de casos desencadeados pelo consumo de novas substâncias psicoativas: relatório 21/12/2012. Lisboa: Direção Geral de Saúde.

 

NPS TOP 10 in Poland. (2014).
Main Sanitary Inspectorate. Retrieved from
http://www.gis.gov.pl/dep/?dep=9&id=13

 

Report on New Drugs in Poland. (2011).
State Sanitary Inspectorate. Retrieved from
http://www.gis.gov.pl/ckfinder/userfiles/files/%C5%9Arodki%20Zast%C4%99pcze/RAPORT%20W%20SPRAWIE%20DOPALACZY%20-%20NOWYCH%20NARKOTYK%C3%93W.pdf

 

Report on Substitutes.
Three yearsfighting with legal highs in Poland. (2013). State Sanitary Inspectorate. Retrieved from
http://www.gis.gov.pl/ckfinder/userfiles/files/%C5%9Arodki%20Zast%C4%99pcze/raport2013.pdf

 

Rhodes T, Lowndes C, Judd A, Mikhailova LA, Sarang A, Rylkov A, et al.
Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS [Internet]. 2002 Sep 6 [cited 2015 Oct 11];16(13):F25–31. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12218407

 

Rhodes T.
Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy [Internet]. 2009 May [cited 2013 Sep 12];20(3):193–201. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19147339

 

Ribeiro, C.; Guerreiro, C.; Dias, L.; & Costa, J.L. (2013).
Consumos, representações e perceções das novas substâncias psicoativas entre estudantes universitários, 2013. Lisboa: SICAD. Retrieved from
http://www.sicad.pt/PT/EstatisticaInvestigacao/EstudosConcluidos/Paginas/detalhe.aspx?itemId=12&lista=SICAD_ESTUDOS&bkUrl=/BK/EstatisticaInvestigacao/EstudosConcluidos

 

Romanian national report on drugs 2013 (Chapter 6 –Chapter 4),
published by the Reitox National Focal Point, Romanian National Antidrug Agency, p101-115, p43-51

 

Romanian national report on drugs 2014 (Chapter 6 –Chapter 4),
published by the Reitox National Focal Point, Romanian National Antidrug Agency, p98-103, p49-53

 

Sarosi, P. (2014).
The not-so-balanced approach: policy responses to new psychoactive substances. Budapest: Hungarian Civil Liberties Union.

 

Sepdise. (2012, October 29).
Smart shops - Drogas Legais - Mortes, desresponsabilização, banalização? Perigo? [Forum message]. Hen’s Health Forum.

 

SICAD (2013). Portugal:
New developments, trends and in-depth information on selected issues. 2013 National report (2012 data) to the EMCDDA by the Reitox national focal point. Lisbon: EMCDDA & SICAD.

 

SICAD (2013-2015).
Plano estratégico 2013-2015. Lisbon: SICAD. Retrieved from
http://www.sicad.pt/BK/Lists/SICAD_NOVIDADES/Attachments/3/plano_estrategico_2013-2015.pdf

 

Sieniawska A. (2013).
“New psychoactive substances in Poland. Study on the phenomenon.” Warsaw: Polish Drug Policy Network (in cooperation with Hungarian Civil Liberties Union).

 

Silva, R. R. (2013, April/May).
O fim das “drogas legais” em Portugal. Boletim da Ordem dos Advogados, 101/102: 30-32.

 

Silva, V. (2005).
Techno, House e Trance: Uma incursão pelas culturas da “dance music.” Toxicodependências, 11 (3): 63-73.

 

Sobera-Madej S. (2013).
Assessment of the impact
of NPS on human health based on chemical structure, physicochemical properties and toxicological studies. Warsaw: Main Sanitary Inspectorate.

 

Sol, C. P. (2013, February 4).
ASAE investiga todas as "smart shops" do país. Radio Renascença. Retrieved from
http://rr.sapo.pt/informacao_detalhe.aspx?fid=25&did=95425

 

Sousa, F. (2014, May 28).
PJ, FFUP E FCUL vão investigar novas drogas. Canal Superior. Retrieved from
http://informacao.canalsuperior.pt/noticia/17925

 

Soussan, C. & Kjellgren, A. (2014).
Harm reduction and knowledge exchange -a qualitative analysis of drug-related Internet discussion forums. Harm reduction journal, 11, 25. doi:10.1186/1477-7517-11-25

 

Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al.
HIV and risk environment for injecting drug users: the past, present, and future. Lancet [Internet]. 2010 Jul 24 [cited 2013 Sep 12];376(9737):268–84. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20650523

 

Study among intensive NPS users 2011, A. Botescu et all,
UNODC Romania

 

Sway. (2012, October 29).
Smart shops - Drogas Legais - Mortes, desresponsabilização, banalização? Perigo? [Forum message]. Hen’s Health Forum. Retrieved from

 

The Gallup Organization. (2011).
Youth attitudes on drugs. Luxemburg: Publications Office of the European Union. Retrieved from
http://ec.europa.eu/public_opinion/flash/fl_330_en.pdf

 

United Nations (1971).
Convention on Psychotropic Substances.


UNODC (2014).
NPS substance groups.

 

Van Hout MC. Kitchen chemistry:
A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. Drug Test Anal [Internet]. Jan [cited 2015 Oct 4];6(7-8):778–87. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/24619569

 

Wodowski, G., Michalewski,B. 2015.
New psychoactive substances in Poland - The report from rapid assessment & response. Krakow: MONAR

 

ZeM. (2012, October 30).
Smart shops - Drogas Legais - Mortes, desresponsabilização, banalização? Perigo? [Forum message]. Hen’s Health Forum.

 

Zinberg N.
Drug, Set, and Setting. The Basis for Controlled Intoxicant Use. [Internet]. New Haven: Yale University; 1984 [cited 2015 Jun 5]. Available from:
http://yalepress.yale.edu/book.asp?isbn=9780300036343

 

 

 

Defining NPS

New to Whom?

UNODC defines new psychoactive substancesor NPS as:... read more

 

Defining Target Groups

Defining the Project’s target audience or end beneficiaries comes with considerable difficulties. The official project title... read more

 

 

publications

 

Project News

nps mini

Addictology, the Czech based journal for research into addiction, published a special issue on NPS related articles, including those with the outcomes of the NPS in Europe project.
read more...

nps mini

The NPS staff presented project outcomes at the International Harm Reduction Conference in Kuala Lumpur, Malaysia.
read more...


nps mini
SEMINAR
NPS Policy: Moving Forward
Leading European experts, including researchers, practitioners and policy makers will meet at a Seminar in Lisbon on the 26th of November to discuss the latest developments in the field of New Psychoactive Substances (NPS).
read more...

nps mini
The NPS in Europe project organises a training on new psychoactive substances (nps), 23 - 25 November 2015 in Lisbon, Portugal. The training is aimed at service provider and peers, supporting NPS users in Europe. The course will give an overview of relevant NPS substances, identify current patterns and develop effective harm reduction service responses.
read more..

Practical information...


nps mini
NPS in Europe

is launching a questionnaire on NPS use in all European countries.